Found 2 publications.
Displayed publications from 1 to 2
Expand all publications
Collapse all publications
Show all as text (SweetDB notation)
Show all graphically (SNFG notation)
1. (Article ID: 8666)
Piirainen MA, Boer H, Ruijter JC, Frey AD
A dual approach for improving homogeneity of a human-type N-glycan structure in Saccharomyces cerevisiae
Glycoconjugate Journal 33(2) (2016)
189-199
N-glycosylation is an important feature of therapeutic and other industrially relevant proteins, and engineering of the N-glycosylation pathway provides opportunities for developing alternative, non-mammalian glycoprotein expression systems. Among yeasts, Saccharomyces cerevisiae is the most established host organism used in therapeutic protein production and therefore an interesting host for glycoengineering. In this work, we present further improvements in the humanization of the N-glycans in a recently developed S. cerevisiae strain. In this strain, a tailored trimannosyl lipid-linked oligosaccharide is formed and transferred to the protein, followed by complex-type glycan formation by Golgi apparatus-targeted human N-acetylglucosamine transferases. We improved the glycan pattern of the glycoengineered strain both in terms of glycoform homogeneity and the efficiency of complex-type glycosylation. Most of the interfering structures present in the glycoengineered strain were eliminated by deletion of the MNN1 gene. The relative abundance of the complex-type target glycan was increased by the expression of a UDP-N-acetylglucosamine transporter from Kluyveromyces lactis, indicating that the import of UDP-N-acetylglucosamine into the Golgi apparatus is a limiting factor for efficient complex-type N-glycosylation in S. cerevisiae. By a combination of the MNN1 deletion and the expression of a UDP-N-acetylglucosamine transporter, a strain forming complex-type glycans with a significantly improved homogeneity was obtained. Our results represent a further step towards obtaining humanized glycoproteins with a high homogeneity in S. cerevisiae.
glycoengineering, N-glycosylation, glycosylation efficiency, yeast, MNN1, UDP-GlcNAc transporter
NCBI PubMed ID: 26983412Publication DOI: 10.1007/s10719-016-9656-4Journal NLM ID: 8603310Publisher: Kluwer Academic Publishers
Correspondence: Frey AD
aalto.fi>
Institutions: VTT Technical Research Centre of Finland, Espoo, Finland, Department of Biotechnology and Chemical Technology, Aalto University, Espoo, Finland
Methods: MALDI-TOF MS, enzymatic digestion, reduction with NaCNBH3, 2-aminobenzamine labelling
The publication contains the following compound(s):
- Compound ID: 21500
|
a-D-Manp-(1-6)-+
|
a-D-Manp-(1-3)-b-D-Manp-(1-4)-b-D-GlcpNAc-(1-4)-D-GlcNAc-ol-(1-2)-Subst-(?--/2-aminobenzamide/
Subst = 2-aminobenzamide = SMILES C1=CC={2}C(C(=C1)C(=O)N)N |
Show graphically |
Structure type: oligomer
; 1053 [M+Na]+
C41H66N4O26
Aglycon: 2-aminobenzamide
Compound class: N-glycan
- Compound ID: 21501
|
a-D-Manp-(1-3)-+
|
a-D-Manp-(1-2)-a-D-Manp-(1-6)-b-D-Manp-(1-4)-b-D-GlcpNAc-(1-4)-D-GlcNAc-ol-(1-2)-Subst-(?--/2-aminobenzamide/
Subst = 2-aminobenzamide = SMILES C1=CC={2}C(C(=C1)C(=O)N)N |
Show graphically |
Structure type: oligomer
; 1215 [M+Na]+
C47H76N4O31
Aglycon: 2-aminobenzamide
Compound class: N-glycan
- Compound ID: 21503
|
a-D-Manp-(1-3)-+
|
a-D-Manp-(1-6)-+ |
| |
a-D-Manp-(1-3)-a-D-Manp-(1-6)-b-D-Manp-(1-4)-b-D-GlcpNAc-(1-4)-D-GlcNAc-ol-(1-2)-Subst-(?--/2-aminobenzamide/
Subst = 2-aminobenzamide = SMILES C1=CC={2}C(C(=C1)C(=O)N)N |
Show graphically |
Structure type: oligomer
; 1377 [M+Na]+
C53H86N4O36
Aglycon: 2-aminobenzamide
Compound class: N-glycan
- Compound ID: 21504
|
b-D-GlcpNAc-(1-2)-a-D-Manp-(1-3)-+
|
a-D-Manp-(1-6)-+ |
| |
a-D-Manp-(1-3)-a-D-Manp-(1-6)-b-D-Manp-(1-4)-b-D-GlcpNAc-(1-4)-D-GlcNAc-ol-(1-2)-Subst-(?--/2-aminobenzamide/
Subst = 2-aminobenzamide = SMILES C1=CC={2}C(C(=C1)C(=O)N)N |
Show graphically |
Structure type: oligomer
; 1418 [M+Na]+
C68H107N7O41
Aglycon: 2-aminobenzamide
Compound class: N-glycan
- Compound ID: 21505
|
b-D-GlcpNAc-(1-2)-a-D-Manp-(1-6)-+
|
b-D-GlcpNAc-(1-2)-a-D-Manp-(1-3)-b-D-Manp-(1-4)-b-D-GlcpNAc-(1-4)-D-GlcNAc-ol-(1-2)-Subst-(?--/2-aminobenzamide/
Subst = 2-aminobenzamide = SMILES C1=CC={2}C(C(=C1)C(=O)N)N |
Show graphically |
Structure type: oligomer
; 1460 [M+Na]+
C57H92N6O36
Aglycon: 2-aminobenzamide
Compound class: N-glycan
- Compound ID: 21506
|
b-D-Manp-(1-2)-a-D-Manp-(1-3)-+
|
a-D-Manp-(1-6)-+ |
| |
a-D-Manp-(1-3)-a-D-Manp-(1-6)-b-D-Manp-(1-4)-b-D-GlcpNAc-(1-4)-D-GlcNAc-ol-(1-2)-Subst-(?--/2-aminobenzamide/
Subst = 2-aminobenzamide = SMILES C1=CC={2}C(C(=C1)C(=O)N)N |
Show graphically |
Structure type: oligomer
; 1540 [M+Na]+
C59H96N4O41
Aglycon: 2-aminobenzamide
Compound class: N-glycan
- Compound ID: 21502
|
a-D-Manp-(1-6)-+
|
b-D-GlcpNAc-(1-2)-a-D-Manp-(1-3)-b-D-Manp-(1-4)-b-D-GlcpNAc-(1-4)-D-GlcNAc-ol-(1-2)-Subst-(?--/2-aminobenzamide/
Subst = 2-aminobenzamide = SMILES C1=CC={2}C(C(=C1)C(=O)N)N |
Show graphically |
Structure type: oligomer
; 1257 [M+Na]+
C49H79N5O31
Aglycon: 2-aminobenzamide
Compound class: N-glycan
Expand this publication
Collapse this publication
2. (Article ID: 8716)
Sakaki Y, Tashiro M, Katou M, Sakuma C, Hirano T, Hakamata W, Nishio T
Enzymatic synthesis of novel oligosaccharides from N-acetylsucrosamine and melibiose using Aspergillus niger α-galactosidase, and properties of the products
Bioscience, Biotechnology, and Biochemistry 80(9) (2016)
1836-1842
Two kinds of oligosaccharides, N-acetylraffinosamine (RafNAc) and N-acetylplanteosamine (PlaNAc), were synthesized from N-acetylsucrosamine and melibiose using the transgalactosylation activity of Aspergillus niger α-galactosidase. RafNAc and PlaNAc are novel trisaccharides in which d-glucopyranose residues in raffinose (Raf) and planteose are replaced with N-acetyl-d-glucosamine. These trisaccharides were more stable in acidic solution than Raf. RafNAc was hydrolyzed more rapidly than Raf by α-galactosidase of green coffee bean. In contrast, RafNAc was not hydrolyzed by Saccharomyces cerevisiae invertase, although Raf was hydrolyzed well by this enzyme. These results indicate that the physicochemical properties and steric structure of RafNAc differ considerably from those of Raf.
oligosaccharide, transgalactosylation, N-acetylplateosamine, N-acetylraffinosamine, α-galactosidase
NCBI PubMed ID: 27254139Publication DOI: 10.1080/09168451.2016.1189316Journal NLM ID: 9205717Publisher: Japan Society for Bioscience, Biotechnology, and Agrochemistry
Correspondence: Nishio T
nihon-u.ac.jp>
Institutions: School of Pharmacy, Tokyo University of Pharmacy and Life Science, Tokyo, Japan, Department of Chemistry and Life Science, College of Bioresource Sciences, Nihon University, Fujisawa, Japan, Department of Chemistry, College of Science and Technology, Meisei University, Tokyo, Japan
Methods: 13C NMR, 1H NMR, TLC, ESI-MS, enzymatic digestion, optical rotation measurement, TOCSY, DQF-COSY, HMBC, COSY, HSQC, HSQC-TOCSY, HPCL
The publication contains the following compound(s):
- Compound ID: 21591
Structure type: oligomer
; 568.2 [M+Na]+
Reference(s) to other database(s): GTC:G35848LA
- Compound ID: 21592
Structure type: oligomer
; 568.1 [M+Na]+
Reference(s) to other database(s): GTC:G63946RF
- Compound ID: 21590
Structure type: oligomer
Reference(s) to other database(s): GTC:G98818NM
Expand this publication
Collapse this publication
Total list of publication IDs on all result pages of the current query:
Total list of corresponding CSDB IDs (permanent record IDs):
Execution: 1 sec